Mariapia Morelli, MD
Internal Medicine · Bridgeport, CTNPI 1518344688
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,338 of the $1,889 with a category attached, or 70.8%. Bayer accounts for 79.7% of it on its own, with 1 other manufacturer making up the rest.
Across 8 payments — averaging $236.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$2K
- Intera Oncology, Inc$383
Across 1 payment — averaging $214,071 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$214K
What the payments were for
- Consulting fees$1,33871%
- Food & beverage$55129%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 5 | $1,505 |
| Intera Oncology, Inc | 3 | $383 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,889 in reported general payments places this provider in the 80th percentile of 2,067 internal medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prochlorperazine Maleate | 19 | $297 |
| Ondansetron Hcl | 17 | $99 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Bridgeport
- Nicholas DainiakBridgeport$352K
- Adrian KlufasBridgeport$17K
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$1.6M
- Arthur DecillisMadison$1M
- Charles MontanoCromwell$970K
- Gary BlickNorwalk$683K
- Scott GottliebStamford$508K
- Jeffrey KatzOxford$361K
- Thomas PellechiGreenwich$196K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.